Sec Form 13G Filing - Microscience Investments LTD filing for Emergent BioSolutions Inc. (EBS) - 2007-03-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

CUSIP No. 29089Q 10 5

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Microscience Investments Limited (in liquidation)

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

x

(b)

o

3.

SEC Use Only

4.

Citizenship or Place of Organization
United Kingdom

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power

6.

Shared Voting Power
0 shares (As of December 31, 2006, the Reporting Person owned 3,636,801 shares of common stock and was a party to a voting agreement with BioPharm, L.L.C., whereby the Reporting Person had agreed to vote all shares of the Issuer’s common stock owned by it in the same manner and to the same extent as BioPharm, L.L.C.  On March 8, 2007, pursuant to a solvent liquidation process, the Reporting Person distributed all of the shares of the Issuer’s common stock owned by it to eligible shareholders of the Reporting Person.)

7.

Sole Dispositive Power
0 shares (See note in Row 6 above)

8.

Shared Dispositive Power

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
0 shares (See note in Row 6 above)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

11.

Percent of Class Represented by Amount in Row (9)

12.

Type of Reporting Person (See Instructions)
OO

Item 1.

(a)

Name of Issuer
Emergent BioSolutions Inc.

(b)

Address of Issuer’s Principal Executive Offices
300 Professional Drive
Suite 250
Gaithersburg, Maryland 20879

Item 2.

(a)

Name of Person Filing
Microscience Investments Limited (in liquidation)

(b)

Address of Principal Business Office or, if none, Residence
c/o BDO Stoy Hayward LLP
8 Baker Street
London
W1U 3LL
United Kingdom
Fax: +44 (0)20 7935 3944

(c)

Citizenship
United Kingdom

(d)

Title of Class of Securities
Common Stock, $0.001 par value

(e)

CUSIP Number
29089Q 10 5

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

o

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

o

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

o

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)

Amount beneficially owned:   

Not applicable

(b)

Percent of class:   

Not applicable

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote   

Not applicable

(ii)

Shared power to vote or to direct the vote    

0 shares (See note in Item 5 below)

(iii)

Sole power to dispose or to direct the disposition of   

0 shares (See note in Item 5 below)

(iv)

Shared power to dispose or to direct the disposition of   

Not applicable

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   x.

As of December 31, 2006, the Reporting Person owned 3,636,801 shares of common stock and was a party to a voting agreement with BioPharm, L.L.C., whereby the Reporting Person had agreed to vote all shares of the Issuer’s common stock owned by it in the same manner and to the same extent as BioPharm, L.L.C.  On March 8, 2007, pursuant to a solvent liquidation process, the Reporting Person distributed all of the shares of the Issuer’s common stock owned by it to eligible shareholders of the Reporting Person.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable

Item 8.

Identification and Classification of Members of the Group

Not applicable

Item 9.

Notice of Dissolution of Group

Not applicable

Item 10.

Certification

March 8, 2007

Date

Microscience Investments Limited (in liquidation)

/s/ Malcolm Cohen

Signature

Malcolm Cohen
Liquidator, acting as agent of the Company
and without personal liability

Name/Title